Literature DB >> 20045004

Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation.

Susan Chung1, D Kent Arrell, Randolph S Faustino, Andre Terzic, Petras P Dzeja.   

Abstract

Decoding of the bioenergetic signature underlying embryonic stem cell cardiac differentiation has revealed a mandatory transformation of the metabolic infrastructure with prominent mitochondrial network expansion and a distinctive switch from glycolysis to oxidative phosphorylation. Here, we demonstrate that despite reduction in total glycolytic capacity, stem cell cardiogenesis engages a significant transcriptome, proteome, as well as enzymatic and topological rearrangement in the proximal, medial, and distal modules of the glycolytic pathway. Glycolytic restructuring was manifested by a shift in hexokinase (Hk) isoforms from Hk-2 to cardiac Hk-1, with intracellular and intermyofibrillar localization mapping mitochondrial network arrangement. Moreover, upregulation of cardiac-specific enolase 3, phosphofructokinase, and phosphoglucomutase and a marked increase in glyceraldehyde 3-phosphate dehydrogenase (GAPDH) phosphotransfer activity, along with apparent post-translational modifications of GAPDH and phosphoglycerate kinase, were all distinctive for derived cardiomyocytes compared to the embryonic stem cell source. Lactate dehydrogenase (LDH) isoforms evolved towards LDH-2 and LDH-3, containing higher proportions of heart-specific subunits, and pyruvate dehydrogenase isoforms rearranged between E1alpha and E1beta, transitions favorable for substrate oxidation in mitochondria. Concomitantly, transcript levels of fetal pyruvate kinase isoform M2, aldolase 3, and transketolase, which shunt the glycolytic with pentose phosphate pathways, were reduced. Collectively, changes in glycolytic pathway modules indicate active redeployment, which would facilitate connectivity of the expanding mitochondrial network with ATP utilization sites. Thus, the delineated developmental dynamics of the glycolytic phosphotransfer network is integral to the remodeling of cellular energetic infrastructure underlying stem cell cardiogenesis. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  bioenergetics; cardiogenesis; embryonic stem cells; proteomics; transcriptome

Mesh:

Substances:

Year:  2010        PMID: 20045004      PMCID: PMC2837789          DOI: 10.1016/j.yjmcc.2009.12.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  61 in total

1.  Large-scale phosphorylation analysis of mouse liver.

Authors:  Judit Villén; Sean A Beausoleil; Scott A Gerber; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

Review 2.  Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics.

Authors:  D K Arrell; N J Niederländer; C Perez-Terzic; S Chung; A Behfar; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2007-08-01       Impact factor: 6.875

Review 3.  The regulation of ion channels and transporters by glycolytically derived ATP.

Authors:  P Dhar-Chowdhury; B Malester; P Rajacic; W A Coetzee
Journal:  Cell Mol Life Sci       Date:  2007-12       Impact factor: 9.261

4.  High glucose induces adipogenic differentiation of muscle-derived stem cells.

Authors:  Paola Aguiari; Sara Leo; Barbara Zavan; Vincenzo Vindigni; Alessandro Rimessi; Katiuscia Bianchi; Chiara Franzin; Roberta Cortivo; Marco Rossato; Roberto Vettor; Giovanni Abatangelo; Tullio Pozzan; Paolo Pinton; Rosario Rizzuto
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

5.  Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II.

Authors:  S Miyamoto; A N Murphy; J H Brown
Journal:  Cell Death Differ       Date:  2007-12-07       Impact factor: 15.828

6.  Defective metabolic signaling in adenylate kinase AK1 gene knock-out hearts compromises post-ischemic coronary reflow.

Authors:  Petras P Dzeja; Peter Bast; Darko Pucar; Be Wieringa; Andre Terzic
Journal:  J Biol Chem       Date:  2007-08-17       Impact factor: 5.157

7.  Mitochondrial DNA replication during differentiation of murine embryonic stem cells.

Authors:  Joao M Facucho-Oliveira; Jon Alderson; Emma C Spikings; Stuart Egginton; Justin C St John
Journal:  J Cell Sci       Date:  2007-10-30       Impact factor: 5.285

Review 8.  Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1.

Authors:  Gregg L Semenza
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

9.  A high glycolytic flux supports the proliferative potential of murine embryonic stem cells.

Authors:  Hiroshi Kondoh; Matilde E Lleonart; Yasuhiro Nakashima; Masayuki Yokode; Makoto Tanaka; David Bernard; Jesus Gil; David Beach
Journal:  Antioxid Redox Signal       Date:  2007-03       Impact factor: 8.401

10.  Cardiopoietic programming of embryonic stem cells for tumor-free heart repair.

Authors:  Atta Behfar; Carmen Perez-Terzic; Randolph S Faustino; D Kent Arrell; Denice M Hodgson; Satsuki Yamada; Michel Puceat; Nicolas Niederländer; Alexey E Alekseev; Leonid V Zingman; Andre Terzic
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307

View more
  74 in total

Review 1.  Metabolic requirements for the maintenance of self-renewing stem cells.

Authors:  Keisuke Ito; Toshio Suda
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04       Impact factor: 94.444

Review 2.  K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.

Authors:  D Kent Arrell; Jelena Zlatkovic Lindor; Satsuki Yamada; Andre Terzic
Journal:  Cardiovasc Res       Date:  2011-02-14       Impact factor: 10.787

3.  Mitochondrial function in engineered cardiac tissues is regulated by extracellular matrix elasticity and tissue alignment.

Authors:  Davi M Lyra-Leite; Allen M Andres; Andrew P Petersen; Nethika R Ariyasinghe; Nathan Cho; Jezell A Lee; Roberta A Gottlieb; Megan L McCain
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

Review 4.  Hexokinases and cardioprotection.

Authors:  Guillaume Calmettes; Bernard Ribalet; Scott John; Paavo Korge; Peipei Ping; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

5.  Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes.

Authors:  Kavitha T Kuppusamy; Daniel C Jones; Henrik Sperber; Anup Madan; Karin A Fischer; Marita L Rodriguez; Lil Pabon; Wei-Zhong Zhu; Nathaniel L Tulloch; Xiulan Yang; Nathan J Sniadecki; Michael A Laflamme; Walter L Ruzzo; Charles E Murry; Hannele Ruohola-Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

Review 6.  Metabolic restructuring and cell fate conversion.

Authors:  Alessandro Prigione; María Victoria Ruiz-Pérez; Raul Bukowiecki; James Adjaye
Journal:  Cell Mol Life Sci       Date:  2015-01-14       Impact factor: 9.261

7.  SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells.

Authors:  Kirstie E Keller; Zainab M Doctor; Zachary W Dwyer; Young-Sam Lee
Journal:  Mol Cell       Date:  2014-03-06       Impact factor: 17.970

8.  Mitochondria in control of cell fate.

Authors:  Clifford D L Folmes; Petras P Dzeja; Timothy J Nelson; Andre Terzic
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

9.  Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.

Authors:  Yao-An Shen; Chia-Yu Wang; Yi-Tao Hsieh; Yann-Jang Chen; Yau-Huei Wei
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.